Stockreport

Sanofi drug Dupixent wins U.S. FDA approval to treat asthma [Reuters]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi drug Dupixent wins U.S. FDA approval to treat asthma | Reuters 2 Min Read Oct 19 (Reuters) - France’s Sanofi SA said on Friday eczema drug Dupixent was approved b [Read more]